ScoreWhy is Sun Pharma Advanced Research Company Ltd ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -24.65% and Operating profit at -1.19% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -141.22
2
With a fall in Operating Profit of -6.73%, the company declared Very Negative results in Sep 25
- The company has declared negative results for the last 2 consecutive quarters
- PAT(Latest six months) At Rs -127.72 cr has Grown at -41.02%
- NET SALES(Q) Lowest at Rs 7.86 cr
- INTEREST(Q) Highest at Rs 7.52 cr
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -29.42%, its profits have risen by 34.6%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -29.42% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is SPARC for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
SPARC
-29.38%
-0.59
50.18%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-24.65%
EBIT Growth (5y)
-9.56%
EBIT to Interest (avg)
-141.22
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.21
Sales to Capital Employed (avg)
1.21
Tax Ratio
0.08%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.81%
ROCE (avg)
-339.84%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
-14.39
EV to EBIT
-21.00
EV to EBITDA
-21.97
EV to Capital Employed
75.69
EV to Sales
90.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-360.41%
ROE (Latest)
Negative BV
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-21What is not working for the Company
PAT(Latest six months)
At Rs -127.72 cr has Grown at -41.02%
NET SALES(Q)
Lowest at Rs 7.86 cr
INTEREST(Q)
Highest at Rs 7.52 cr
Loading Valuation Snapshot...
Here's what is not working for SPARC
Net Sales - Quarterly
At Rs 7.86 cr has Fallen at -51.3% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 16.15 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit After Tax (PAT) - Latest six months
At Rs -127.72 cr has Grown at -41.02%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Net Sales - Quarterly
Lowest at Rs 7.86 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Interest - Quarterly
Highest at Rs 7.52 cr
in the last five quarters and Increased by 21.49 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
